Amalgamated Bank Atara Biotherapeutics, Inc. Transaction History

Amalgamated Bank

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.44 - $1.22 $2,690 - $7,460	-6,115 Reduced 65.53%	3,216 $2,000
Q4 2023 Feb 06, 2024	SELL	$0.23 - $1.74 $220 - $1,665	-957 Reduced 9.3%	9,331 $5,000
Q2 2023 Aug 11, 2023	BUY	$1.5 - $3.04 $142 - $288	95 Added 0.93%	10,288 $16,000
Q1 2023 May 02, 2023	SELL	$2.8 - $5.46 $4,930 - $9,615	-1,761 Reduced 14.73%	10,193 $30,000
Q3 2022 Nov 09, 2022	BUY	$2.85 - $8.73 $88 - $270	31 Added 0.26%	11,954 $45,000
Q2 2022 Aug 15, 2022	BUY	$4.69 - $9.84 $5,285 - $11,089	1,127 Added 10.44%	11,923 $93,000
Q1 2022 Jun 30, 2022	SELL	$8.44 - $16.89 $4,886 - $9,779	-579 Reduced 5.09%	10,796 $100,000
Q4 2021 Feb 15, 2022	BUY	$14.7 - $19.89 $3,219 - $4,355	219 Added 1.96%	11,375 $179,000
Q3 2021 Oct 29, 2021	SELL	$11.99 - $17.9 $9,448 - $14,105	-788 Reduced 6.6%	11,156 $200,000
Q2 2021 Aug 16, 2021	BUY	$12.89 - $16.58 $22,866 - $29,412	1,774 Added 17.44%	11,944 $186,000
Q1 2021 May 13, 2021	SELL	$14.0 - $20.72 $3,724 - $5,511	-266 Reduced 2.55%	10,170 $146,000
Q4 2020 Feb 12, 2021	BUY	$12.67 - $26.23 $132,224 - $273,736	10,436 New	10,436 $204,000
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $120,853 - $260,357	-6,344 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.4 - $41.74 $7,156 - $10,518	252 Added 4.14%	6,344 $252,000
Q4 2018 Feb 15, 2019	BUY	$30.9 - $42.97 $188,242 - $261,773	6,092 New	6,092 $212,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $217,169 - $269,526	-6,196 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$35.15 - $51.45 $217,789 - $318,784	6,196 New	6,196 $228,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.